Difference between revisions of "Normative:MRNA vaccine"
Jump to navigation
Jump to search
(Created page with "==Normative== === Spelling variants === ===Synonyms=== * ===Definition=== Source: === Encyclopaedic information === Source: ===Examples=== '''1)''' Source: ===Collocat...") |
(new addition) |
||
Line 1: | Line 1: | ||
==Normative== | ==Normative== | ||
=== | === Encyclopaedic information === | ||
People with HIV were included in the clinical trials of the two mRNA vaccines and the adenovirus vector vaccine that are currently available through Emergency Use Authorizations (EUAs) from the Food and Drug Administration;18-20 however, the safety and efficacy of these vaccines in people with HIV have not been reported. | |||
<small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | |||
Source: | |||
=== | ===Examples=== | ||
Source: | <blockquote>The '''mRNA vaccines''' contain polyethylene glycol (PEG), and the Johnson & Johnson (J&J)/Janssen vaccine contains polysorbate.</blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
=== | ===Collocations=== | ||
* SARS-CoV-2 mRNA vaccine | |||
* | * | ||
===Keyness=== | ===Keyness=== | ||
* mRNA vaccine: >1000 | |||
===Note=== | ===Note=== | ||
relatively rare (only 9 occurrences) |
Latest revision as of 09:40, 6 March 2022
Normative
Encyclopaedic information
People with HIV were included in the clinical trials of the two mRNA vaccines and the adenovirus vector vaccine that are currently available through Emergency Use Authorizations (EUAs) from the Food and Drug Administration;18-20 however, the safety and efficacy of these vaccines in people with HIV have not been reported.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Examples
The mRNA vaccines contain polyethylene glycol (PEG), and the Johnson & Johnson (J&J)/Janssen vaccine contains polysorbate.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Collocations
- SARS-CoV-2 mRNA vaccine
Keyness
- mRNA vaccine: >1000
Note
relatively rare (only 9 occurrences)